文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Triglyceride and Glucose Index as a Screening Tool for Nonalcoholic Liver Disease in Patients with Metabolic Syndrome.

作者信息

Amzolini Anca Maria, Forțofoiu Mircea-Cătălin, Alhija Anca Barău, Vladu Ionela Mihaela, Clenciu Diana, Mitrea Adina, Forțofoiu Maria, Matei Daniela, Diaconu Magdalena, Tudor Marinela Sinziana, Micu Elena Simona

机构信息

Department of Medical Semiology, Faculty of Medicine, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.

Department of Internal Medicine 2, "Philanthropy" Clinical Municipal Hospital of Craiova, 200143 Craiova, Romania.

出版信息

J Clin Med. 2022 May 28;11(11):3043. doi: 10.3390/jcm11113043.


DOI:10.3390/jcm11113043
PMID:35683431
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9181222/
Abstract

BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) is regarded as a component of metabolic syndrome, which involves insulin resistance (IR) as the primary physiopathological event. The aim of this study was to establish the association between IR, assessed using the triglyceride and glucose index (TyG), and histopathological features of NAFLD lesions. METHODS: The study included 113 patients with metabolic syndrome. Fasting plasma glucose (FPG), fasting lipid profiles and liver enzymes were measured. IR was assessed by the TyG index. Liver biopsy was performed for assessment steatosis and fibrosis. RESULTS: the TyG index had a mean value of 8.93 ± 1.45, with a higher value in the patients with overweight ( = 0.002) and obesity ( = 0.004) characteristics than in the patients with normal weight. The TyG index mean value was 8.78 ± 0.65 in subjects without NASH, 8.91 ± 0.57 in patients with borderline NASH and 9.13 ± 0.55 in patients with definite NASH. A significant difference was found between subjects without NASH and the ones with definite NASH ( = 0.004), as well as in patients with early fibrosis vs. those with significant fibrosis. The analysis of the area under the ROC curve proved that the TyG index is a predictor of NASH ( = 0.043). CONCLUSION: the TyG index is a facile tool that can be used to identify individuals at risk for NAFLD.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab83/9181222/98c96e95a728/jcm-11-03043-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab83/9181222/8270fde16611/jcm-11-03043-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab83/9181222/c6ffa72b79f8/jcm-11-03043-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab83/9181222/25a36b87f1e4/jcm-11-03043-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab83/9181222/7466e9ed5cec/jcm-11-03043-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab83/9181222/98c96e95a728/jcm-11-03043-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab83/9181222/8270fde16611/jcm-11-03043-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab83/9181222/c6ffa72b79f8/jcm-11-03043-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab83/9181222/25a36b87f1e4/jcm-11-03043-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab83/9181222/7466e9ed5cec/jcm-11-03043-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab83/9181222/98c96e95a728/jcm-11-03043-g005.jpg

相似文献

[1]
Triglyceride and Glucose Index as a Screening Tool for Nonalcoholic Liver Disease in Patients with Metabolic Syndrome.

J Clin Med. 2022-5-28

[2]
The triglycerides and glucose (TyG) index: A new marker associated with nonalcoholic steatohepatitis (NASH) in obese patients.

Diabetes Metab. 2022-7

[3]
Triglyceride Glucose Index and Related Parameters (Triglyceride Glucose-Body Mass Index and Triglyceride Glucose-Waist Circumference) Identify Nonalcoholic Fatty Liver and Liver Fibrosis in Individuals with Overweight/Obesity.

Metab Syndr Relat Disord. 2021-4

[4]
Triglyceride and glucose index: a useful tool for non-alcoholic liver disease assessed by liver biopsy in patients with metabolic syndrome?

Rom J Morphol Embryol. 2021

[5]
PERFORMACE OF TRIGLYCERIDE-GLUCOSE INDEX ON DIAGNOSIS AND STAGING OF NAFLD IN OBESE PATIENTS.

Arq Gastroenterol. 2021

[6]
Triglyceride-Glucose Index for Early Prediction of Nonalcoholic Fatty Liver Disease: A Meta-Analysis of 121,975 Individuals.

J Clin Med. 2022-5-9

[7]
IMPACT OF TYPE 2 DIABETES ON NONALCOHOLIC STEATOHEPATITIS AND ADVANCED FIBROSIS IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE.

Endocr Pract. 2020-1-22

[8]
The product of triglycerides and glucose as biomarker for screening simple steatosis and NASH in asymptomatic women.

Ann Hepatol. 2016

[9]
Triglyceride Glucose Index Is Superior to the Homeostasis Model Assessment of Insulin Resistance for Predicting Nonalcoholic Fatty Liver Disease in Korean Adults.

Endocrinol Metab (Seoul). 2019-6

[10]
A longitudinal epidemiological study on the triglyceride and glucose index and the incident nonalcoholic fatty liver disease.

Lipids Health Dis. 2018-11-20

引用本文的文献

[1]
Association between triglyceride-glucose index and liver enzymes in adults with metabolic syndrome: a retrospective cross-sectional study.

Ann Med. 2025-12

[2]
A Prospective Controlled Study on the Longitudinal Effects of Rehabilitation in Older Women with Primary Sarcopenia.

Life (Basel). 2025-4-6

[3]
Pathophysiological mechanisms and benefits of SGLT?2 inhibitors in a patient with cerebral artery aneurysm: A case report.

Exp Ther Med. 2025-4-4

[4]
Metabolic Syndrome and Insulin Resistance in Romania.

Int J Mol Sci. 2025-3-7

[5]
Comprehensive Gait Analysis and Kinetic Intervention for Overweight and Obese Children.

Children (Basel). 2025-1-23

[6]
The burden of cancer in metabolic dysfunction-associated steatotic liver disease.

Rom J Morphol Embryol. 2024

[7]
Predictive Value of the Triglyceride-Glucose Index for Metabolic-Associated Fatty Liver Disease in Individuals with Different Metabolic Obese Phenotypes.

Diabetes Metab Syndr Obes. 2025-1-15

[8]
Inflammation and Physical Performance in Overweight and Obese Schoolchildren.

Life (Basel). 2024-12-1

[9]
Efficacy and Safety of GLP-1 Receptor Agonists in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Cureus. 2024-10-13

[10]
The triglyceride and glucose index and risk of nonalcoholic fatty liver disease: A dose-response meta-analysis.

Front Endocrinol (Lausanne). 2022

本文引用的文献

[1]
Impact of direct acting antivirals (DAAs) on cardiovascular events in HCV cohort with pre-diabetes.

Nutr Metab Cardiovasc Dis. 2021-7-22

[2]
The triglyceride-glucose index is associated with the severity of hepatic steatosis and the presence of liver fibrosis in non-alcoholic fatty liver disease: a cross-sectional study in Chinese adults.

Lipids Health Dis. 2020-10-7

[3]
Reduced incidence of type 2 diabetes in patients with chronic hepatitis C virus infection cleared by direct-acting antiviral therapy: A prospective study.

Diabetes Obes Metab. 2020-12

[4]
Impact of hepatitis C virus clearance by direct-acting antiviral treatment on the incidence of major cardiovascular events: A prospective multicentre study.

Atherosclerosis. 2020-3

[5]
Triglyceride Glucose Index Is Superior to the Homeostasis Model Assessment of Insulin Resistance for Predicting Nonalcoholic Fatty Liver Disease in Korean Adults.

Endocrinol Metab (Seoul). 2019-6

[6]
A longitudinal epidemiological study on the triglyceride and glucose index and the incident nonalcoholic fatty liver disease.

Lipids Health Dis. 2018-11-20

[7]
Liver biopsy in type 2 diabetes mellitus: Steatohepatitis represents the sole feature of liver damage.

PLoS One. 2017-6-1

[8]
The triglyceride and glucose index (TyG) is an effective biomarker to identify nonalcoholic fatty liver disease.

Lipids Health Dis. 2017-1-19

[9]
Histological factors that predict the liver fibrosis in patients with chronic hepatitis C.

Rom J Morphol Embryol. 2016

[10]
The product of triglycerides and glucose as biomarker for screening simple steatosis and NASH in asymptomatic women.

Ann Hepatol. 2016

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索